Drugplain

INFLUENZINUM 15 [hp_C]/1

INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) · PELLET · Boiron

1 Recall on Record
Plain English

INFLUENZINUM is a pellet containing influenza b virus b/phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated), influenza b virus b/michigan/01/2021 hemagglutinin antigen (formaldehyde inactivated), influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/thailand/8/2022 ivr-237 (h3n2) hemagglutinin antigen (formaldehyde inactivated) at 15 [hp_C]/1, taken oral. Manufactured by Boiron.

Key Facts

Brand Name
INFLUENZINUM
Generic Name
INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
NDC Code (Product)
0220-5094
Manufacturer
Boiron
Strength
15 [hp_C]/1
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
10/01/2024

Recall History

1 Recall on Record
Class II05/13/2022

Washington Homeopathic Products, Inc.

cGMP deviations

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

angioedema1 reports
aortic dilatation1 reports
back pain1 reports
blood pressure increased1 reports
cerebrovascular accident1 reports
contusion1 reports
dysphagia1 reports
dysphonia1 reports
eyelid oedema1 reports
face oedema1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Relieves after effects of flu or flu-like symptoms * See symptoms on front panel.

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Frequently Asked Questions

What is INFLUENZINUM used for?

INFLUENZINUM contains INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED). It is a pellet taken oral. Consult your doctor for specific uses.

Is INFLUENZINUM a controlled substance?

INFLUENZINUM is not classified as a controlled substance by the DEA.

What is the generic name for INFLUENZINUM?

The generic name for INFLUENZINUM is INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED). There are no other listed brand versions of INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED).

What is the NDC code for INFLUENZINUM 15 [hp_C]/1?

The NDC (National Drug Code) for INFLUENZINUM 15 [hp_C]/1 is 0220-5094, listed by Boiron.

Product NDC

0220-5094

Package NDC

0220-5094-41

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)